PLYMOUTH – ProNAi Therapeutics announced that it has added five seasoned executives to its senior management team.
They include:
Dr. Angie You, Chief Business & Strategy Officer & Head of Commercial
Wendy Chapman, Senior Vice President, Clinical Operations
Chandra Lovejoy, Senior Vice President, Global Regulatory Affairs & Quality
Emma McCann, Vice President, Program Management
James Smith, Vice President, Corporate Affairs
“We are rapidly building a professional leadership team to ensure our lead oncology drug, PNT2258, has the best prospects for clinical and commercial success, while also focusing on advancing a broad oncology pipeline built upon our novel and proprietary DNAi platform,” said Dr. Nick Glover, President & CEO of ProNAi Therapeutics. “These executives add deep experience in clinical trial execution, regulatory negotiation and capital markets access, and are essential to the further growth of our company. In addition, Dr. Angie You, our Chief Business & Strategy Officer and Head of Commercial has an outstanding track record in the biotech industry and will be responsible for leading the development and operationalization of our growth-oriented strategic plan, including the anticipated North American commercialization of our oncology products.”
